|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0008976,
umls-concept:C0012634,
umls-concept:C0024501,
umls-concept:C0030705,
umls-concept:C0043227,
umls-concept:C0205224,
umls-concept:C0301625,
umls-concept:C0441655,
umls-concept:C0596545,
umls-concept:C1516240
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-1-13
|
|
pubmed:abstractText |
To explore the impact of an early treatment response on maintenance of work capacity in patients with early, active rheumatoid arthritis (RA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
pubmed-author:AhonenJariJ,
pubmed-author:COTEJ FJF,
pubmed-author:FIN-RACo Trial Group,
pubmed-author:ForsbergSinikkaS,
pubmed-author:HakalaMarkkuM,
pubmed-author:JärvinenPenttiP,
pubmed-author:KautiainenHannuH,
pubmed-author:KorpelaMarkkuM,
pubmed-author:Leirisalo-RepoMarjattaM,
pubmed-author:MöttönenTimoT,
pubmed-author:PuolakkaKariK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
36-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15641055-Adult,
pubmed-meshheading:15641055-Anti-Inflammatory Agents,
pubmed-meshheading:15641055-Antirheumatic Agents,
pubmed-meshheading:15641055-Arthritis, Rheumatoid,
pubmed-meshheading:15641055-Disability Evaluation,
pubmed-meshheading:15641055-Drug Therapy, Combination,
pubmed-meshheading:15641055-Female,
pubmed-meshheading:15641055-Humans,
pubmed-meshheading:15641055-Hydroxychloroquine,
pubmed-meshheading:15641055-Male,
pubmed-meshheading:15641055-Methotrexate,
pubmed-meshheading:15641055-Middle Aged,
pubmed-meshheading:15641055-Prednisolone,
pubmed-meshheading:15641055-Remission Induction,
pubmed-meshheading:15641055-Sick Leave,
pubmed-meshheading:15641055-Sulfasalazine,
pubmed-meshheading:15641055-Time Factors,
pubmed-meshheading:15641055-Work Capacity Evaluation
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
|
|
pubmed:affiliation |
Department of Medicine, Lappeenranta Central Hospital, Valto Käkelän katu 1, Lappeenranta FIN-53130, Finland. kari.puolakka@fimnet.fi
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
